Nutex Health Inc. (NASDAQ:NUTX) Short Interest Up 40.3% in March

Nutex Health Inc. (NASDAQ:NUTX) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 84,600 shares, an increase of 40.3% from the March 15th total of 60,300 shares. Based on an average trading volume of 56,800 shares, the days-to-cover ratio is currently 1.5 days. Approximately 2.6% of the shares of the stock are short sold.

Nutex Health Price Performance

Shares of NUTX stock opened at $149.00 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. Nutex Health has a 12-month low of $4.16 and a 12-month high of $151.30. The firm has a fifty day moving average of $71.04 and a 200-day moving average of $46.10. The firm has a market capitalization of $823.67 million, a price-to-earnings ratio of -15.87 and a beta of 0.27.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The company had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.13 million.

Insiders Place Their Bets

In other news, CFO Jon Christian Bates bought 1,000 shares of the company’s stock in a transaction dated Tuesday, April 8th. The stock was bought at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now directly owns 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 38.52% of the company’s stock.

Institutional Trading of Nutex Health

Several hedge funds and other institutional investors have recently modified their holdings of the company. Bank of America Corp DE boosted its position in shares of Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after buying an additional 2,043 shares during the period. Beaird Harris Wealth Management LLC bought a new stake in Nutex Health in the 3rd quarter valued at approximately $69,000. Northern Trust Corp acquired a new position in Nutex Health during the 4th quarter worth approximately $200,000. Baader Bank Aktiengesellschaft bought a new position in shares of Nutex Health during the 4th quarter worth approximately $206,000. Finally, Millennium Management LLC acquired a new stake in shares of Nutex Health in the fourth quarter valued at approximately $213,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Maxim Group upped their price target on Nutex Health from $75.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 8th.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.